Business Finland allocates significant funding to GlucoModicum

Business Finland has carefully monitored GlucoModicum progress and future plans concerning non-invasive biomarker monitoring. Based on that Business Finland has decided to allocate significant additional funding to GlucoModicum. Thank you Business Finland for your support!